HCM III Acquisition Corp. (Nasdaq: HCMA) is a blank-check company formed to pursue a business combination, representing the third SPAC vehicle in the HCM sponsor series. The company filed its annual report on Form 10-K with the SEC on March 30, 2026, covering the fiscal year ended December 31, 2025, with accession number 0001213900-26-035829. As of the filing date, HCMA remained in its search phase, actively seeking an acquisition target in the healthcare and life sciences sector. The "III" designation signals a repeat sponsor team with prior SPAC experience, a profile that institutional investors and deal-watchers typically track closely. For complete filing history, deal timelines, and sponsor analytics on HCMA, sign up for full data access at SpacDesk.